Literature DB >> 2110896

The effect of von Willebrand factor on activation of factor VIII by factor Xa.

J A Koedam1, R J Hamer, N H Beeser-Visser, B N Bouma, J J Sixma.   

Abstract

Factor VIII has to be activated before it can serve efficiently as a cofactor in the intrinsic pathway of blood coagulation. This activation occurs through specific proteolytic cleavages in the molecule by either thrombin or factor Xa. In this study, we show that von Willebrand factor inhibits the activation of factor VIII by factor Xa. Incubation of factor VIII (30 U/ml) with 0.1 microgram/ml factor Xa resulted in a 1.6-fold activation followed by a decay of coagulant activity. In the presence of 10 micrograms/ml von Willebrand factor, activation and inactivation of factor VIII was completely inhibited. In contrast, the activation of factor VIII by thrombin was not influenced by von Willebrand factor. At high concentrations of factor Xa (10 micrograms/ml), von-Willebrand-factor-bound factor VIII could be cleaved and activated. The generated proteolytic fragments were identical to the fragments produced in the absence of von Willebrand factor and all fragments were released from von Willebrand factor. The major products were light-chain-derived fragments of molecular mass 66/68 kDa and 60 kDa and heavy-chain-derived fragments of 40 and 42 kDa. Also minor products of 12, 20/21, 23, 27 and 30 kDa were observed, most of which were specific for cleavage of factor VIII by factor Xa.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110896     DOI: 10.1111/j.1432-1033.1990.tb15481.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa.

Authors:  S W Pipe; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.

Authors:  H J Brinkman; P Koster; K Mertens; J A van Mourik
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A.

Authors:  Kathryn G Link; Michael T Stobb; Matthew G Sorrells; Maria Bortot; Katherine Ruegg; Marilyn J Manco-Johnson; Jorge A Di Paola; Suzanne S Sindi; Aaron L Fogelson; Karin Leiderman; Keith B Neeves
Journal:  J Thromb Haemost       Date:  2019-11-01       Impact factor: 5.824

4.  Distinct roles of Ser-764 and Lys-773 at the N terminus of von Willebrand factor in complex assembly with coagulation factor VIII.

Authors:  Lydia Castro-Núñez; Esther Bloem; Mariëtte G Boon-Spijker; Carmen van der Zwaan; Maartje van den Biggelaar; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

5.  Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.

Authors:  Karin Leiderman; William C Chang; Mikhail Ovanesov; Aaron L Fogelson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-27       Impact factor: 8.311

6.  Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.

Authors:  T C Nichols; C M Samama; D A Bellinger; J Roussi; R L Reddick; M Bonneau; M S Read; O Bailliart; G G Koch; M Vaiman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  The influence of von Willebrand factor on factor VIII activity measurements.

Authors:  S Butenas; B Parhami-Seren; K G Mann
Journal:  J Thromb Haemost       Date:  2008-10-29       Impact factor: 5.824

8.  Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.

Authors:  S Layet; J P Girma; B Obert; E Peynaud-Debayle; N Bihoreau; D Meyer
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

9.  Blood Clotting Factor VIII: From Evolution to Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov; A I Vorobiev
Journal:  Acta Naturae       Date:  2013-04       Impact factor: 1.845

Review 10.  Microfluidic devices for studying coagulation biology.

Authors:  Brady M Trevisan; Christopher D Porada; Anthony Atala; Graça Almeida-Porada
Journal:  Semin Cell Dev Biol       Date:  2020-06-18       Impact factor: 7.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.